Hudson Bay Capital Management
SANA icon

Hudson Bay Capital Management’s Sana Biotechnology SANA Stock Holding History

Hudson Bay Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$28.8K – 1649
2026
Q1 		$28.8K Buy
+10,000
New +$39.4K ﹤0.01% 1310

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Hudson Bay Capital Management's SANA Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 10,000 shares — an estimated $28.8K sold.

Hudson Bay Capital Management first reported a position in SANA in Q1 2026 and held it in 1 quarter. The position peaked at $28.8K in Q1 2026. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 10,000 Sana Biotechnology shares in Q2 2026, an estimated $28.8K.
  • Hudson Bay Capital Management first reported a position in Sana Biotechnology in Q1 2026 and held it in 1 quarter.
  • Hudson Bay Capital Management's Sana Biotechnology position peaked at $28.8K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.